Population-level virulence factors amongst pathogenic bacteria: relation to infection outcome.
about
Biofilm and Helicobacter pylori: from environment to human hostBacterial virulence traits: A potential area of study for drug developmentRegulation of virulence gene expression resulting from Streptococcus pneumoniae and nontypeable Haemophilus influenzae interactions in chronic diseaseGeneration of genic diversity among Streptococcus pneumoniae strains via horizontal gene transfer during a chronic polyclonal pediatric infectionAdenoid reservoir for pathogenic biofilm bacteria.Comparative supragenomic analyses among the pathogens Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae using a modification of the finite supragenome modelCharacterization of bacterial communities in venous insufficiency wounds by use of conventional culture and molecular diagnostic methods.The distributed genome hypothesis as a rubric for understanding evolution in situ during chronic bacterial biofilm infectious processes.Development and validation of an Haemophilus influenzae supragenome hybridization (SGH) array for transcriptomic analysesA novel technique using potassium permanganate and reflectance confocal microscopy to image biofilm extracellular polymeric matrix reveals non-eDNA networks in Pseudomonas aeruginosa biofilmsComparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars.What makes pathogens pathogenic.Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection.Biofilms and Helicobacter pylori: Dissemination and persistence within the environment and host.Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.
P2860
Q27015096-CE90E92F-588C-4919-8FBC-B1D7D02792FBQ28384971-13DBBB81-63E4-48D4-ADC6-1111500CB85CQ28478266-E452E445-ADC5-473D-96A3-37EB1CFF7D4FQ33700577-222C2699-A2AB-4B23-B03A-2A631AC6E6E8Q33816610-32B9D1FA-45EB-458E-AD44-D9EC4A18F2D7Q33871710-7BC09EC0-BF38-41C6-B32A-ABE79F57FAF5Q34006801-4D9B9B59-847B-4C21-AE08-381F19C226F1Q34022518-CA8D45D9-DE27-481D-A7BE-14374E2675F5Q35308667-38FA6341-FC93-4AF4-95FE-3A20A5AB9CC5Q35832428-9FC98806-9058-4ECC-AE4C-0DE38B0469A9Q36156238-B7C75703-39AE-4981-BA8A-EA0D39CF2F44Q37206311-E7A5D34C-67AE-4434-8398-2AA3C20849EDQ38014922-45DDF2C1-62EE-46EA-AC65-B85D00E4F57BQ38240874-CCFE184A-6107-42CF-93A9-964256C0F0C0Q49958760-10BDFF41-9E9D-4EA7-8C22-B37E19945481
P2860
Population-level virulence factors amongst pathogenic bacteria: relation to infection outcome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population-level virulence fac ...... relation to infection outcome.
@en
Population-level virulence fac ...... relation to infection outcome.
@nl
type
label
Population-level virulence fac ...... relation to infection outcome.
@en
Population-level virulence fac ...... relation to infection outcome.
@nl
prefLabel
Population-level virulence fac ...... relation to infection outcome.
@en
Population-level virulence fac ...... relation to infection outcome.
@nl
P2860
P356
P1433
P1476
Population-level virulence fac ...... relation to infection outcome.
@en
P2093
Garth D Ehrlich
P2860
P356
10.2217/17460913.3.1.31
P577
2008-02-01T00:00:00Z